Potent, cell active, non-thiol tetrapeptide inhibitors of farnesyltransferase

被引:93
作者
Hunt, JT [1 ]
Lee, VG [1 ]
Leftheris, K [1 ]
Seizinger, B [1 ]
Carboni, J [1 ]
Mabus, J [1 ]
Ricca, C [1 ]
Yan, N [1 ]
Manne, V [1 ]
机构
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT BIOMOLEC DRUG DISCOVERY,PRINCETON,NJ 08543
关键词
D O I
10.1021/jm9507284
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
All previously reported CAAX-based farnesyltransferase inhibitors contain a thiol functionality. We report that attachment of the 4-imidazolyl group, via 1-, 2-, or 3-carbon alkyl or alkanoyl spacers, to Val-Tic-Met or tLeu-Tic-Gln provides potent FT inhibitors. (R*)-N-[1,2,3,4-Tetrahydro-2-[N-[2-(1H-imidazol-4-yl)ethyl-L-valyl]-3-isoquinolinyl]carbonyl]-L-methionine ([imidazol-4-yl-ethyl]-val-Tic-Met), with FT IC50 = 0.79 nM, displayed potent cell activity in the absence of prodrug formation (SAG EC(50) = 3.8 mu M).
引用
收藏
页码:353 / 358
页数:6
相关论文
共 26 条
[1]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[2]   RATIONAL DESIGN OF POTENT CARBOXYLIC-ACID BASED BISUBSTRATE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE [J].
BHIDE, RS ;
PATEL, DV ;
PATEL, MM ;
ROBINSON, SP ;
HUNIHAN, LW ;
GORDON, EM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (17) :2107-2112
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]  
CECCHI R, 1985, FARMACO-ED SCI, V40, P541
[5]  
CHRISTIANSON DW, 1991, ADV PROTEIN CHEM, V42, P281
[6]  
Cox Adrienne D., 1992, Current Opinion in Cell Biology, V4, P1008, DOI 10.1016/0955-0674(92)90133-W
[7]  
GARCIA AM, 1993, J BIOL CHEM, V268, P18415
[8]   FARNESYLTRANSFERASE INHIBITORS - RAS RESEARCH YIELDS A POTENTIAL CANCER THERAPEUTIC [J].
GIBBS, JB ;
OLIFF, A ;
KOHL, NE .
CELL, 1994, 77 (02) :175-178
[9]  
GOLDSTEIN JL, 1991, J BIOL CHEM, V266, P15575
[10]   PSEUDOPEPTIDE INHIBITORS OF RAS FARNESYL-PROTEIN TRANSFERASE [J].
GRAHAM, SL ;
DESOLMS, SJ ;
GIULIANI, EA ;
KOHL, NE ;
MOSSER, SD ;
OLIFF, AI ;
POMPLIANO, DL ;
RANDS, E ;
BRESLIN, MJ ;
DEANA, AA ;
GARSKY, VM ;
SCHOLZ, TH ;
GIBBS, JB ;
SMITH, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (06) :725-732